SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy's makes investment of Rs 650 crore in Aurigene Oncology

25 May 2024 Evaluate

Dr. Reddy's Laboratories has made an investment of Rs 650 crore in Aurigene Oncology (AOL) and AOL has allotted 9,70,14,896 equity shares of Rs 10 each at a premium of Rs 57 to the company on May 23, 2024. 

The fund infused by the company into AOL will be further invested in Aurigene Pharmaceutical Services (APSL), a wholly-owned subsidiary of AOL and step down wholly owned subsidiary of the company, to support the capex and working capital requirements of APSL.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1232.00 19.65 (1.62%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×